Literature DB >> 29435076

STAT3 promotes the proliferation and migration of hepatocellular carcinoma cells by regulating AKT2.

Yi Xie1, Jianmin Li1, Chao Zhang1.   

Abstract

The aim of the present study was to investigate the correlation of STAT3 and AKT in HCC cells. HCC cells were transfected with si-STAT3 and si-AKT2 in vitro and the mRNA expression of STAT3 and AKT was detected by RT-PCR, and the protein expression was measured by western blot. MTT assays were used to evaluate cell proliferation, and Transwell assays were performed to detect the ability of migration and invasion. The relationship between STAT3 and AKT was analyzed by ChIP and Dual-luciferase reporter (DLR) assays. A nude mice experiment was used to verify the correlation. In the present study, we found that the expression of p-AKT2 and its downstream molecules were reduced in HCC cells transfected with si-STAT3, and the expression of p-STAT3 and its downstream molecules was decreased in HCC cells transfected with si-AKT2. Moreover, the ability of HCC cells proliferation, migration and invasion was decreased in si-STAT3 transfection group, but AKT2 reversed the role of si-STAT3 in HCC cells. The ChIP experiment found that STAT3 could bind to the AKT2 promoter in HCC cells. The DLR assay showed that the luciferase activity of AKT2 promoter was enhanced in HCC cells treated by IL-6. The nude mice experiment found that the tumor grew slowly after transfection with the STAT3-siRNA lentiviral vector, while AKT2 reversed the effect. STAT3 and AKT2 had mutual regulatory relationship, and STAT3 promoted the occurrence and development of HCC by regulating AKT2.

Entities:  

Keywords:  AKT2; HCC; STAT3; migration; proliferation

Year:  2017        PMID: 29435076      PMCID: PMC5778844          DOI: 10.3892/ol.2017.7681

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  22 in total

Review 1.  Stats: transcriptional control and biological impact.

Authors:  David E Levy; J E Darnell
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

2.  Activation of STAT3 by specific Galpha subunits and multiple Gbetagamma dimers.

Authors:  Jessie W F Yuen; Lydia S W Poon; Anthony S L Chan; Frances W Y Yu; Rico K H Lo; Yung H Wong
Journal:  Int J Biochem Cell Biol       Date:  2010-03-27       Impact factor: 5.085

3.  Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer.

Authors:  Marina Lesina; Magdalena U Kurkowski; Katharina Ludes; Stefan Rose-John; Matthias Treiber; Günter Klöppel; Akihiko Yoshimura; Wolfgang Reindl; Bence Sipos; Shizuo Akira; Roland M Schmid; Hana Algül
Journal:  Cancer Cell       Date:  2011-04-12       Impact factor: 31.743

4.  Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression.

Authors:  Akihisa Fukuda; Sam C Wang; John P Morris; Alexandra E Folias; Angela Liou; Grace E Kim; Shizuo Akira; Kenneth M Boucher; Matthew A Firpo; Sean J Mulvihill; Matthias Hebrok
Journal:  Cancer Cell       Date:  2011-04-12       Impact factor: 31.743

5.  Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1.

Authors:  Jinfeng Huang; Yue Wang; Yingjun Guo; Shuhan Sun
Journal:  Hepatology       Date:  2010-07       Impact factor: 17.425

6.  Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.

Authors:  Wen-Chang Li; Sheng-Long Ye; Rui-Xia Sun; Yin-Kun Liu; Zhao-You Tang; Youngsoo Kim; James G Karras; Hong Zhang
Journal:  Clin Cancer Res       Date:  2006-12-01       Impact factor: 12.531

7.  Phospho-akt expression is associated with a favorable outcome in non-small cell lung cancer.

Authors:  Amit Shah; William A Swain; Donna Richardson; John Edwards; Duncan J Stewart; Catherine M Richardson; Daniel E B Swinson; Dipika Patel; J Louise Jones; Kenneth J O'Byrne
Journal:  Clin Cancer Res       Date:  2005-04-15       Impact factor: 12.531

8.  Knockdown of STAT3 expression by RNAi suppresses growth and induces apoptosis and differentiation in glioblastoma stem cells.

Authors:  Guang-Hui Li; Hong Wei; Sheng-Qing Lv; Hua Ji; Dong-Lin Wang
Journal:  Int J Oncol       Date:  2010-07       Impact factor: 5.650

9.  Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment.

Authors:  Marcin Kortylewski; Hong Xin; Maciej Kujawski; Heehyoung Lee; Yong Liu; Timothy Harris; Charles Drake; Drew Pardoll; Hua Yu
Journal:  Cancer Cell       Date:  2009-02-03       Impact factor: 31.743

10.  Stat3-siRNA induces Fas-mediated apoptosis in vitro and in vivo in breast cancer.

Authors:  Sateesh Kunigal; Sajani S Lakka; Prasanna Kumar Sodadasu; Norman Estes; Jasti S Rao
Journal:  Int J Oncol       Date:  2009-05       Impact factor: 5.650

View more
  6 in total

1.  Elevated expression of cellular SYNE1, MMP10, and GTPase1 and their regulatory role in hepatocellular carcinoma progression.

Authors:  Laila H Faraj Shaglouf; Maryam Ranjpour; Saima Wajid; Swatantra Kumar Jain
Journal:  Protoplasma       Date:  2019-08-19       Impact factor: 3.356

2.  Targeting the transcriptional activity of STAT3 by a novel fusion protein.

Authors:  Yanqiong Chen; Wenting Zhang; Xiufeng Bai; Yi Liu
Journal:  BMC Cancer       Date:  2022-07-10       Impact factor: 4.638

3.  Autocrine STAT3 activation in HPV positive cervical cancer through a virus-driven Rac1-NFκB-IL-6 signalling axis.

Authors:  Ethan L Morgan; Andrew Macdonald
Journal:  PLoS Pathog       Date:  2019-06-21       Impact factor: 6.823

Review 4.  Modulating the Crosstalk between the Tumor and Its Microenvironment Using RNA Interference: A Treatment Strategy for Hepatocellular Carcinoma.

Authors:  Mariam Mroweh; Thomas Decaens; Patrice N Marche; Zuzana Macek Jilkova; Flora Clément
Journal:  Int J Mol Sci       Date:  2020-07-24       Impact factor: 5.923

Review 5.  Targeting Akt in Hepatocellular Carcinoma and Its Tumor Microenvironment.

Authors:  Mariam Mroweh; Gaël Roth; Thomas Decaens; Patrice N Marche; Hervé Lerat; Zuzana Macek Jílková
Journal:  Int J Mol Sci       Date:  2021-02-11       Impact factor: 5.923

6.  AKT2 reduces IFNβ1 production to modulate antiviral responses and systemic lupus erythematosus.

Authors:  Xin Zheng; Jun Xiao; Qi Jiang; Lingming Zheng; Chang Liu; Chen Dong; Yuxiao Zheng; Peili Ni; Chi Zhang; Fang Zhang; Ruiyue Zhong; Huihua Ding; Qiong Wang; Ying Qiu; Minxia Gao; Jianping Ding; Nan Shen; Bin Wei; Hongyan Wang
Journal:  EMBO J       Date:  2022-02-22       Impact factor: 11.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.